The estimated Net Worth of Jeffrey Kappler is at least $2.11 million dollars as of 17 November 2021. Mr. Kappler owns over 153 units of Envista Corp stock worth over $658,607 and over the last 5 years he sold NVST stock worth over $1,449,053. In addition, he makes $0 as Senior Vice President at Envista Corp.
Sign up
Mr. Kappler NVST stock SEC Form 4 insiders trading
Jeffrey has made over 7 trades of the Envista Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 153 units of NVST stock worth $6,472 on 17 November 2021.
The largest trade he's ever made was selling 18,550 units of Envista Corp stock on 26 March 2021 worth over $762,776. On average, Jeffrey trades about 2,630 units every 53 days since 2019. As of 17 November 2021 he still owns at least 37,336 units of Envista Corp stock.
You can see the complete history of Mr. Kappler stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jeffrey Kappler biography
Jeffrey S. Kappler serves as Senior Vice President of the Company since September 2019. Prior to that, Mr. Kappler served in various leadership roles for Danaher’s Dental business since January 2015, including as President of the Ormco business since October 2018. Mr. Kappler joined Danaher in December 2007 and held a variety of positions at Danaher, including as Business Unit Manager of Veeder-Root, then a subsidiary of Danaher, from March 2012 to December 2015.
How old is Jeffrey Kappler?
Jeffrey Kappler is 41, he's been the Senior Vice President of Envista Corp since 2019. There are 20 older and no younger executives at Envista Corp. The oldest executive at Envista Holdings Corp is Amir Aghdaei, 62, who is the President, Chief Executive Officer, Director.
What's Jeffrey Kappler's mailing address?
Jeffrey's mailing address filed with the SEC is C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA, CA, 92821.
Insiders trading at Envista Corp
Over the last 5 years, insiders at Envista Corp have traded over $35,099,063 worth of Envista Corp stock and bought 101,717 units worth $1,939,832 . The most active insiders traders include Corp /De/ Danaher, Vivek Jain et Wendy Carruthers. On average, Envista Corp executives and independent directors trade stock every 31 days with the average trade being worth of $320,413. The most recent stock trade was executed by Paul A Keel on 13 August 2024, trading 30,000 units of NVST stock currently worth $506,100.
What does Envista Corp do?
we know that dental professionals do more than create healthy, beautiful smiles—they create confidence. to achieve their goals, they need a champion. they need someone who will be there for them, side by side and end to end. at envista, we are uniquely positioned to be this champion. our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the professionals we serve embolden us to champion dental professionals like no one else can. our comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. we believe true champions lift each other up, and we are looking for new champions to join our team. if you believe, champions do more than win, they stand for something bigger, you can build a meaningful career at envista. if you believe champions work to be their best, help others be theirs, sho
What does Envista Corp's logo look like?
Complete history of Mr. Kappler stock trades at Envista Corp
Envista Corp executives and stock owners
Envista Corp executives and other stock owners filed with the SEC include:
-
Amir Aghdaei,
President, Chief Executive Officer, Director -
Amir Aghdaei,
Pres, CEO & Director -
Patrik Eriksson,
Senior Vice President -
Curt Bludworth,
Chief Human Resource Officer, Senior Vice President -
Howard Yu,
Chief Financial Officer, Senior Vice President -
Patrik Eriksson,
Sr. VP & Pres of Nobel Biocare -
Howard H. Yu,
Sr. VP & CFO -
Mark E. Nance,
Sr. VP, Gen. Counsel & Sec. -
Jean-Claude E. Kyrillos,
Sr. VP and Pres of Imaging & DTX -
Scott Huennekens,
Independent Chairman of the Board -
Christine Tsingos,
Independent Director -
Wendy Carruthers,
Independent Director -
Kieran Gallahue,
Independent Director -
Daniel Raskas,
Director -
John Bedford,
Vice President - Investor Relations -
Gayle Sheppard,
Independent Director -
Vivek Jain,
Independent Director -
Mischa Reis,
Senior Vice President - Strategy and Corporate Development -
Jean-Claude Kyrillos,
Senior Vice President and President of the KaVo Kerr Business -
Jeffrey Kappler,
Senior Vice President -
Mark Nance,
Senior Vice President, General Counsel, Secretary -
Curt W. Bludworth,
Sr. VP & Chief HR Officer -
Mischa M. Reis,
Sr. VP of Strategy & Corp. Devel. -
Juan Arbona,
Chief Compliance Officer -
John C. Moten,
VP of Investor Relations -
Kari-Lyn Moore,
VP & Chief Accounting Officer -
Robert Befidi,
President, Diagnostics -
Paul A Keel,
Chief Executive Officer -
Corp /De/ Danaher,
10% owner -
William K Daniel,
Director -
Hans Geiselhoeringer,
SENIOR VICE PRESIDENT -
Eric Conley,
SVP, Orthodontics -
Barbara B. Hulit,
Director -
Stephen Keller,
Principal Financial Officer -
Faez C Kaabi,
Chief Accounting Officer -
Eric D. Hammes,
Chief Financial Officer